Evidências sobre a eficácia e limitações dos antidepressivos ISRS no tratamento da depressão maior
Major depressive disorder is an important public health problem, affecting functioning and quality of life. This study aims to evaluate the efficacy and limitations of selective serotonin reuptake inhibitors (SSRIs) in adults with major depression. It is a qualitative, descriptive literature review based on national and international publications addressing clinical response, tolerability, adherence, and treatment continuity. Evidence discussed in the theoretical background indicates benefits of antidepressants compared with placebo, although individual differences in response and limitations related to adverse events, early discontinuation, and access to care remain. Fluoxetine, used in the Brazilian public health system, and escitalopram are relevant drugs for within-class comparisons. The preliminary conclusion is that SSRIs remain important therapeutic options, but their use requires individualized assessment of efficacy, safety, and adherence. The structured selection of studies must be completed before definitive review results can be reported.
Authors
- Carlos Alberto de Paula Dias Neto
- Anna Clara Barbosa Gomes
- Adriano de Sá Peixoto Teles
Publication Details
- Journal
- Revista fisio&terapia.
- Published
- 2026-11-15
- DOI
- https://doi.org/10.69849/gb9jny19
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00